Skip to main content

Table 2 Fetal adverse outcome by severity of HDP during pregnancy (Total)

From: Characteristics and fetal outcomes of pregnant women with hypertensive disorders in China: a 9-year national hospital-based cohort study

 

Normal

Elevated

Stage1

Non-severe stage2

Severe stage2

Preterm delivery at < 37 weeks

 Frequency, n (%)

1078(10.41)

1042(10.90)

6076(10.61)

34,128(14.20)

27,838(30.86)

 OR (95% CI)

ref.

1.05(0.93 ~ 1.19)

1.02(0.91 ~ 1.14)

1.42(1.25 ~ 1.62)

5.02(4.36 ~ 5.79)

 aOR (95% CI)

ref.

1.08(0.95 ~ 1.23)

1.09(0.97 ~ 1.23)

1.67(1.46 ~ 1.91)

5.44(4.70 ~ 6.28)

SGA (< 10th percentile)

 Frequency, n (%)

1179(11.40)

1031(10.80)

7195(12.57)

36,925(15.37)

21,313(28.27)

 OR (95% CI)

ref.

0.94(0.83 ~ 1.07)

1.12(1.00 ~ 1.25)

1.41(1.24 ~ 1.61)

3.06(2.66 ~ 3.53)

 aOR (95% CI)

ref.

1.01(0.87 ~ 1.16)

1.21(1.07 ~ 1.38)

1.55(1.34 ~ 1.79)

3.20(2.74 ~ 3.73)

Stillbirth

 Frequency, n (%)

98(0.95)

78(0.82)

462(0.81)

2495(1.04)

2242(2.96)

 OR (95% CI)

ref.

0.86(0.64 ~ 1.17)

0.85(0.68 ~ 1.06)

1.10(0.86 ~ 1.41)

3.20(2.51 ~ 4.08)

 aOR (95% CI)

ref.

0.97(0.71 ~ 1.33)

0.97(0.77 ~ 1.23)

1.20(0.92 ~ 1.56)

2.55(1.96 ~ 3.32)

Neonatal death

 Frequency, n (%)

25(0.24)

18(0.19)

101(0.18)

501(0.21)

484(0.64)

 OR (95% CI)

ref.

0.78(0.46 ~ 1.33)

0.73(0.45 ~ 1.18)

0.86(0.55 ~ 1.34)

2.66(1.71 ~ 4.15)

 aOR (95% CI)

ref.

0.85(0.50 ~ 1.44)

0.81(0.51 ~ 1.29)

0.98(0.62 ~ 1.54)

2.24(1.42 ~ 3.54)

low Apgar score

 Frequency, n (%)

51(0.50)

34(0.36)

228(0.40)

1243(0.53)

1241(1.71)

 OR (95% CI)

ref.

0.72(0.47 ~ 1.10)

0.81(0.60 ~ 1.10)

1.06(0.78 ~ 1.42)

3.48(2.55 ~ 4.73)

 aOR (95% CI)

ref.

0.77(0.51 ~ 1.14)

0.88(0.67 ~ 1.17)

1.10(0.83 ~ 1.45)

2.92(2.20 ~ 3.89)